Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company,
is scheduled to participate in the following upcoming investor
conferences:

Event: Stifel Nicolaus Healthcare Conference
Date: Thursday, September 16, 2010
Time: 10:20 a.m. ET
Location: Four Seasons Hotel
200 Boylston Street
Boston, Mass.
Speaker: Gearoid Faherty, Chairman and Chief Executive Officer

Event: UBS Global Life Sciences Conference
Date: Monday, September 20, 2010
Time: 9:00 a.m. ET
Location: Grand Hyatt Hotel
Park Avenue at Grand Central
New York, N.Y.
Speaker: John Fraher, Chief Commercial Officer

An audio webcast of the Company's presentations at each conference
will be available by accessing the investor relations section of
www.eurand.com (http://www.eurand.com) and will be available via
replay for 30 days following the date of the presentation.

About Eurand

Eurand is a specialty pharmaceutical company that develops,
manufactures and commercializes enhanced pharmaceutical and
biopharmaceutical products based on its proprietary pharmaceutical
technologies. Eurand has had six products approved by the FDA since
2001 and has a pipeline of product candidates in development for
itself and its collaboration partners. Its technology platforms
include bioavailability enhancement of poorly soluble drugs, custom
release profiles and taste-masking orally disintegrating tablet (ODT)
formulations. Eurand is a global company with facilities in the U.S.
and Europe. For more information, visit www.eurand.com
(http://www.eurand.com) .